ApoB level genotype and LDL subclass phenotype independently contribute to the risk of familial combined hyperlipidemia, highlighting the complex genetic heterogeneity of the disorder.
No takes yet. Share an insight, caveat, or question.
Should not yet change FCHL management; leaves open validation of these loci for risk stratification.
Jarvik et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: